These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 20087155

  • 21. Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy.
    Santoro-Lopes G, de Pinho AM, Harrison LH, Schechter M.
    Clin Infect Dis; 2002 Feb 15; 34(4):543-6. PubMed ID: 11797184
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries.
    Harries AD, Maher D, Nunn P.
    Bull World Health Organ; 1997 Feb 15; 75(5):477-89. PubMed ID: 9447782
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
    Elzi L, Schlegel M, Weber R, Hirschel B, Cavassini M, Schmid P, Bernasconi E, Rickenbach M, Furrer H, Swiss HIV Cohort Study.
    Clin Infect Dis; 2007 Jan 01; 44(1):94-102. PubMed ID: 17143823
    [Abstract] [Full Text] [Related]

  • 27. Secular trends of tuberculosis in western Europe.
    Raviglione MC, Sudre P, Rieder HL, Spinaci S, Kochi A.
    Bull World Health Organ; 1993 Jan 01; 71(3-4):297-306. PubMed ID: 8324847
    [Abstract] [Full Text] [Related]

  • 28. Risk factors for active tuberculosis in adults on highly active antiretroviral therapy in Africa.
    Seyler C, Toure S, Messou E, Anglaret X.
    AIDS; 2006 Jun 26; 20(10):1463; author reply 1463-5. PubMed ID: 16791027
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Characteristics and response to antiretroviral therapy of HIV-1-infected patients born in Africa and living in France.
    Breton G, Lewden C, Spire B, Salmon D, Brun-Vézinet F, Duong M, Allavena C, Leport C, Salamon R, APROCO COPILOTE ANRS CO8 Study Group.
    HIV Med; 2007 Apr 26; 8(3):164-70. PubMed ID: 17461860
    [Abstract] [Full Text] [Related]

  • 31. [Tuberculosis--recurrence of a forgotten infectious disease?].
    Fengler JD.
    Z Arztl Fortbild (Jena); 1995 Jun 26; 89(3):223-7. PubMed ID: 7668008
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Ireland addresses HIV and migration.
    Hargreaves S.
    Lancet Infect Dis; 2008 Aug 26; 8(8):470. PubMed ID: 18705070
    [No Abstract] [Full Text] [Related]

  • 34. [Tuberculosis among AIDS patients in Ullev]l hospital].
    Berild D.
    Tidsskr Nor Laegeforen; 1995 Nov 10; 115(27):3361-4. PubMed ID: 7491576
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Impact of immigration and HIV infection on tuberculosis incidence in an area of low tuberculosis prevalence.
    Baussano I, Bugiani M, Gregori D, Pasqualini C, Demicheli V, Merletti F.
    Epidemiol Infect; 2006 Dec 10; 134(6):1353-9. PubMed ID: 16623989
    [Abstract] [Full Text] [Related]

  • 38. Tuberculosis is important problem in children with HIV infection in sub-Saharan Africa.
    Maher D.
    BMJ; 1996 Aug 31; 313(7056):562-3. PubMed ID: 8790012
    [No Abstract] [Full Text] [Related]

  • 39. [Tuberculosis and migrants].
    Med Mal Infect; 2004 Aug 31; 34(8-9):397-8. PubMed ID: 15622985
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.